-
Onglyza Study Confirms Increased Risk of Heart Failure
November 11, 2015 |Legal News, Pharmaceuticals -
FDA Wants Zoloft Label to Warn of Birth Defects Risk
November 11, 2015 |Legal News, Pharmaceuticals -
Lipitor Diabetes Link Reconfirmed in Recent BMJ Study
November 11, 2015 |Legal News, Pharmaceuticals -
Propecia Sexual Dysfunction Can Have Serious Consequences
November 11, 2015 |Legal News, Pharmaceuticals -
Zofran Birth Defects Lawsuits Consolidated into MDL in Massachusetts
November 10, 2015 |GlaxoSmithKline Consumer Healthcare Class Action Lawsuit and Settlement News, Legal News, Pharmaceuticals -
Dangerous Rash Among Zithromax’s Side Effects
November 10, 2015 |Legal News, Pharmaceuticals -
Dilantin May Cause Focal Cerebral Atrophy, or Shrinking Brain
November 10, 2015 |Legal News, Pharmaceuticals -
FDA Panel Advises Heart Failure Warning Label Update for Onglyza
November 10, 2015 |Legal News, Pharmaceuticals -
FDA Commissions Industry Study of Testosterone Side Effects
November 10, 2015 |Legal News, Pharmaceuticals -
Massachusetts Resident Files Lipitor Diabetes Lawsuit
November 9, 2015 |Legal News, Pharmaceuticals -
Xarelto Lawsuit Alleges Blood Thinner Caused Life-Threatening Internal Bleeding
November 9, 2015 |Legal News, Pharmaceuticals -
Propecia Bellwether Trials Postponed to 2017
November 9, 2015 |Legal News, Pharmaceuticals
Pharmaceuticals
Attorneys
Work With Us
Top Class Actions has helped law firms across the country successfully find plaintiffs for class action lawsuits & mass torts since 2008, receiving tens of thousands of leads per month. We also can push your legitimate claim rate up to 25%, depending on your settlement, with our various strategies to broadcast your message.
Get in Touch













